Sobi names new VP, manufacturing
This article was originally published in Scrip
Swedish Orphan Biovitrum (Sobi), which develops treatments for rare diseases, has named Kirsti Gjellan senior vice-president of manufacturing operations – effective September 2014. Prior to joining Sobi, Ms Gjellan was managing director and site leader at Pfizer's Strängnäs site, as well as a member of Pfizer Health's board. She succeeds Lena Nyström, who is retiring later this year.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.